Consultants
Innate Therapeutic's small but experienced staff are complemented by world class advisors and consultants.
Michael Silverman
Michael Silverman, M.D., F.A.C.P., Trials consultant - FDA clinical trials strategic and operational planning. Dr Silverman formerly directed clinical trials at the Sterling Winthrop Research Institute, managed therapeutics R&D at the Sandoz Research Institute, and gained biotech/small pharma start-up company experience heading Clinical Research at Telor and Biopure. In 1997 he was part of KPMGs Pharmaceutical Strategy Group before founding BioStrategics Consulting Ltd. Brief Biography
Benjamin Segal
Benjamin Segal, M.D., Clinical Consultant (Multiple Sclerosis). Dr Segal is the Holtom-Garrett Professor of Neurology; Director, University of Michigan Multiple Sclerosis Center; and Director, Holtom-Garrett Program in Neuroimmunology at Ann Arbor, MI. Brief Biography
Jim Taylor
Jim Taylor, Ph.D., Trials consultant - FDA regulatory affairs & manufacturing. Dr. Taylor was formerly Corporate VP and Chief Regulatory Officer for ImmunoGen, Inc, VP of Regulatory Affairs for Carter-Wallace, North American Director of Drug Regulatory Affairs for ICI Pharmaceuticals (now Astra-Zeneca) and a Senior Research Scientist and Regulatory Liaison Officer for Pfizer, Inc. He has extensive experience in pharmaceutical regulatory Affairs, GMP compliance, quality assurance and project management including active preparation and/or support for more than 50 new INDs in addition to ongoing advice and support for many investigational and marketed drug and biological products. Brief Biography
Fred Reno
Fred Reno, Ph.D., Toxicology consultant. Dr Reno is an internationally renowned consulting toxicologist providing expertise in the areas of preclinical aspects of drug development, strategies for product safety valuation, and liaison with regulatory agencies. With over 35 years experience, including 20 years with Hazelton Laboratories, Dr. Reno's experience includes organizing and directing safety evaluation programs and interfacing with contract laboratories, providing scientific opinions on toxicology aspects of potential candidate compounds for licensing, and preparation of preclinical summaries for US (IND and NDA) and foreign pharmaceutical submissions to regulatory agencies.
Related Pages:
Our People - Directors View page...
Our People - Senior Management View page...
Our People - Collaborators View page...